Search

for
Search:

GlossaryCutaneous T-Cell Lymphoma (CTCL)

rare skin cancer involving malignant T-cells

Cutaneous T-Cell Lymphoma (CTCL) is a rare type of non-Hodgkin lymphoma that primarily affects the skin. It involves malignant T-cells, a type of white blood cell, which accumulate in the skin and cause symptoms such as red, scaly patches, plaques, or tumors.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 108 results

research Cutaneous T-Cell Lymphoma Outcomes During COVID-19

September 2021 in “Journal of the American Academy of Dermatology”

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

research Hair Follicle-Derived IL-7 and IL-15 Mediate Skin-Resident Memory T Cell Homeostasis and Lymphoma

245 citations, October 2015 in “Nature medicine”

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

research Interferon in the Treatment of Cutaneous T-Cell Lymphoma

107 citations, December 2003 in “Dermatologic Therapy”

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

research Current Management Strategies for Cutaneous T-Cell Lymphoma

39 citations, May 2004 in “Clinics in Dermatology”

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

research Phase II Evaluation of VDC-1101 in Canine Cutaneous T-Cell Lymphoma

28 citations, September 2014 in “Journal of Veterinary Internal Medicine”

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

View more "ctcl" in research →

Community Join

0 / 0 results

— no results